Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
5 hedge funds and large institutions have $75.1K invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
731% more capital invested
Capital invested by funds: $9.04K → $75.1K (+$66.1K)
25% more funds holding
Funds holding: 4 → 5 (+1)
0.56% more ownership
Funds ownership: 0.05% → 0.61% (+0.56%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$68.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$14.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Simplex Trading
Chicago,
Illinois
|
-$5.23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $60.3K | +$68.4K | +5,834 | +8,707% |
|
|
2
UBS Group
Zurich,
Switzerland
| $12.5K | +$14.4K | +1,225 | New |
|
|
3
Simplex Trading
Chicago,
Illinois
| $1.23K | -$5.23K | -446 | -79% |
|
|
FC
4
Financial Consulate
Hunt Valley,
Maryland
| $1.02K | – | – | – |
|
5
Morgan Stanley
New York
| $29 | – | – | – |
|
PILL Hedge Fund Activity: Q1 2026 in Review
5 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q1 2026, worth a combined $75.1K — up 731% from $9.04K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PILL positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $68.4K. The largest seller was Simplex Trading, cutting an estimated $5.23K.
- 5 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q1 2026, up from 4 in Q4 2025.
- Funds reported $75.1K of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q1 2026, up 731% quarter-over-quarter.
- 1 fund opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q1 2026 and 0 closed out, a net change of +1 holder.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q1 2026 was Tower Research Capital (TRC), an estimated $68.4K added.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q1 2026 was Simplex Trading, an estimated $5.23K sold.
Based on aggregated 13F filings for Q1 2026.